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1036-300 A Novel Proteomic Interaction Involving the
Cytoplasmic Loop of Connexin43 and Tubulin
Pritha P. Gupta, Eunice Kang, Marc Ponzio, Adam Butensky, David E. Gutstein, NYU 
School of Medicine, New York, NY
Background: Gap junctions are intercellular channels that are composed of connexins. 
Electrical signals are passed efﬁciently through the gap junctions, allowing the heart to 
contract synchronously. Gap junctions are trafﬁcked to the membrane by microtubules, 
which are composed of tubulin proteins. Other groups have identiﬁed an interaction 
between tubulin and the C-terminus (CT) of connexin43 (Cx43), but a similar interaction 
has not been demonstrated in other connexins. We hypothesized that protein-protein 
interactions relevant to trafﬁcking may exist involving other regions of the Cx43 molecule 
and that these interactions may be generalized to other members of the connexin protein 
family.
Methods: To investigate novel protein-protein interactions, we constructed a glutathione 
S-transferase (GST)-fusion product with the cytoplasmic loop (CL) of Cx43. GST-
pulldowns using mouse brain lysate were performed to identify novel binding partners 
to the GST-Cx43 CL fusion product. Novel interacting proteins observed using 2-D gel 
electrophoresis were subsequently identiﬁed with mass spectrometry.
Results: Protein fractionation with 2-D gels indicated multiple novel proteomic interactions 
with the CL of Cx43, which were identiﬁed as including alpha- and beta-tubulin. Western 
blot analysis was then performed on GST-pulldown products to conﬁrm the interaction 
of beta-tubulin with the CL of Cx43. To establish an approximate ratio of tubulin afﬁnity 
for the CL versus the CT of Cx43, different ratios of GST-Cx43 CT:GST-Cx43 CL were 
analyzed. Results indicated that the CL of Cx43 has approximately 5X greater afﬁnity for 
beta-tubulin than does the Cx43-CT. Comparison of sequence structure between the CL 
of Cx43 and microtubule-associated protein 1B (MAP-1B) revealed a region of extensive 
homology, which may represent an area with high afﬁnity for beta-tubulin.
Conclusion: Our study suggests that the CL of Cx43 may contain motifs for tubulin binding 
that are critical for membrane trafﬁcking and, hence, gap junction formation. This novel 
proteomic interaction may represent an important therapeutic target in cardiac disease 
conditions involving abnormal gap junction trafﬁcking.
1036-301 Long QT Syndrome: The Inﬂuence of Menopause on
Cardiac Events
Jehu S. Mathew, Arthur J. Moss, Scott McNitt, Ilan Goldenberg, Wojciech Zareba, 
Ming Qi, Jennifer L. Robinson, International Long QT Syndrome Investigative Group, 
University of Rochester Medical Center, Rochester, NY
Background: Risk stratiﬁcation ﬁndings in Long QT Syndrome (LQTS) have demonstrated 
that females have a high rate of cardiac events before age 40. To evaluate the inﬂuence 
of estrogen on LQTS, we assessed the clinical course of LQTS females before, during, 
and after menopause.
Methods: The study involved 1,624 women, with 560 having undergone menopause. 
The primary endpoint was the occurrence of any cardiac event (syncope, aborted 
cardiac arrest, or LQTS-related sudden death) between the ages of 20 and 70 years. 
The Anderson-Gill proportional hazards ratio (HR) model was applied to assess the 
risk of multiple events during the pre-, peri-, and post-menopausal time intervals. The 
occurrence of multiple events was also assessed by determining annualized cardiac 
event rates before (BM) and after (AM) menopause, with further stratiﬁcation by the 
absence (-PS) or presence (+PS) of a history of prior syncope before age 20 as well as 
by QTc and genotype.
Results: Of the 560 patients who had undergone menopause, the mean age at menopause 
was 47 years. During the study period, syncope comprised the majority of events (94%). 
The Anderson-Gill analysis showed that peri- (HR = 0.017, p <0.001) and post- (HR = 
0.069, p <0.001) menopause intervals were associated with signiﬁcant reductions in risk 
during follow-up compared to pre-menopause. When assessing annualized cardiac event 
rates, meaningfully lower cardiac event rates were seen after menopause. This held true 
when patients were grouped by prior syncope (+PS: 8.21 events/year BM versus 2.26 
events/year AM; -PS: 1.81 events/year BM versus 0.62 events/year AM), by QTc (+PS, 
QTc q 500 msec: 9.68 events/year BM versus 2.35 events/year AM), and by genotype 
(+PS, LQT2: 11.86 events/year BM versus 1.91 events/year AM). 
Conclusions: The post-menopausal state is associated with a signiﬁcant decrease in the 
risk of cardiac events in LQTS women. The ﬁndings are consistent with reduced LQTS-
related arrhythmias from dimished estrogen levels after menopause. 
1036-302 Relationship Between Catheter Force, Popping and
Char Formation: Experience With Robotic Navigation
Luigi Di Biase, Jennifer E. Cummings, Conor Barrett, Robert A. Schweikert, Chi Keong 
Ching, Mauricio Arruda, J. David Burkhardt, Andrea Natale, Walid I. Saliba, Cleveland 
Clinic, Cleveland, OH
INTRODUCTION: Popping, char and perforation are complications of catheter ablation. 
We measured the amount of grams applied to the endocardium with a robotic system. 
We evaluated the relationship between pressure and the development of such 
complications.
METHODS:Using a robotic navigation system, transeptal puncture was performed and 
an open irrigated ablation catheter (OIC) was advanced into the left atrium (LA) in 6 
dogs. Lesions were placed in the LA atrium at 6 settings (Table 1), using a constant 
duration (40 sec). Lesion delivery was monitored using intracardiac echocardiography 
(ICE). Sudden impedance rise, audible pops, and bubble showers were noted. Necropsy 
was then performed.
RESULTS: Lesions using 30 W were more likely to be transmural at higher (>40 gr) than 
lower (<30 gr) pressures (50% vs 16.7% p<0.05). Signiﬁcantly higher number of lesions 
using >40gr of pressure demonstrated “popping” and crater formation as compared to 
lesions with 20-30gr of pressure (41.7% vs 16.7%, p<0.05). The majority of lesions placed 
using higher power (45W) with higher pressures (>40 gr) were associated with char and 
crater formation (66.1%). No lesions using 10 gr of pressure were transmural, regardless 
of the power.
CONCLUSIONS: When using an OIC, higher catheter pressure is more likely to result in 
a transmural lesion. However, this also appears to be related to char, crater formation and 
“popping”. Moderate pressures (20-30g) were associated with transmurality with lower 
incidence of complications. 
Group Power (W) Pressure (g) % Transmurality % Complication (Char, popping)
Group 1 30 10 0% 0%
Group 2 45 10 0% 0%
Group 3 30 20-30 16.7% 0%
Group 4 45 20-30 83.1% 33.3%
Group 5 30 >40 50% 16.7%
Group 6 45 >40 100% 66.7%
1036-303 Socioeconomic Position Is a Predictor of Graft Failure
in Pediatric Heart Transplant Recipients
Tajinder P. Singh, Kimberlee Gauvreau, Elizabeth D. Blume, Heather Bastardi, John E. 
Meyer, Children’s Hospital Boston, Boston, MA
Background: Socioeconomic (SE) position can affect resources and health-related 
behavior. We evaluated whether patient SE position, determined for the block group of 
patient residence (average population 1000), is associated with graft failure in pediatric 
heart TX recipients.
Methods: We used the American census 2000 database to extract 6 variables of wealth, 
income, education, and occupation for each TX recipient and calculated a summed SE 
z-score for recipients who survived to discharge at our institution between 1990 and 2005 
(n=126). Multivariate Cox proportional hazards models were used to determine the risk 
of graft failure (Time to death or re-TX) in the lowest tertile SE group (low SE group) 
compared to the remaining 2/3 patients (controls).
Results: The median age at the time of TX was 8.9 years (range 6 day to 23 years). The 2 
groups were similar with respect to age, gender, diagnosis and year of TX. White race was 
less frequent in low SE group (67% versus 90%, P<0.01). Graft failure occurred in 37 TX 
recipients. In univariate analysis, low SE group (Hazard ratio (HR) 2.3, 95% conﬁdence 
interval (CI) 1.2-4.4) and nonwhite race (HR 2.9, 95% CI 1.4-5.9) were both associated 
with higher risk of graft failure. In a model controlling for age, diagnosis, era and race (HR 
2.5, 95% CI 1.2-5.4), low SE position remained signiﬁcantly associated with graft failure 
(HR 2.1, 95% CI 1.0-4.3, P=0.04).
Conclusions: : Low SE position is an independent risk factor for graft failure in pediatric 
heart TX recipients. 
1036-304 Continuous Flow Left Ventricular Assist Device as
a Bridge to Cardiac Transplantation: Long-Term
Outcomes
Joseph G. Rogers, Leslie W. Miller, Francis D. Pagani, Keith D. Aaronson, Ranjit John, 
Andrew J. Boyle, Carmelo A. Milano, Stuart D. Russell, John V. Conte, Yoshifumi Naka, 
Donna Mancini, Roberta C. Bogaev, Thomas E. MacGillivray, David J. Farrar, O. H. 
Frazier, for the HeartMate II Investigators, Duke University, Durham, NC
Background: The HeartMate II (HMII) left ventricular assist device (LVAD) is a small, 
continuous ﬂow blood pump being evaluated in patients (pts) awaiting transplantation and 
in pts who are not transplant candidates. We report the updated 1-year outcomes from the 
bridge to transplant (BTT) study that includes pts in the original cohort as well as those 
enrolled into the continued access program.
Methods: Cardiac transplant candidates (n=327) listed as UNOS status 1A or 1B, most 
of whom required intravenous inotropic support, were enrolled at 32 US centers in a 
prospective evaluation of safety and efﬁcacy endpoints. The ﬁrst 194 pts were implanted q
12 months ago and are reported here. The median support duration was 131 days (range: 
1-844 days) and the cumulative follow-up represents 109 pt-years of support.
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Results: At 12 months, 149/194 (77%) pts survived with 53% undergoing transplantation, 
22% remaining on the device and 2% having the device removed following cardiac recovery. 
Forty two pts (22%) died after a median duration of 48 days and 3 pts were withdrawn 
from the study (days 1, 15, and 32) because surgical complications necessitated pump 
replacement with a different LVAD. The Kaplan Meier survival for pts continuing on support 
was 78 ± 3%, 70 ± 4%, and 68 ± 5% at 6, 12 and 18 months, respectively. Compared to 
baseline, measures of exercise performance (6 minute walk distance increased by 297 ± 
28 m), functional capacity (85% with NYHA Class I or II), and quality of life (Kansas City 
Cardiomyopathy Questionnaire scores increased by 96%) were all improved at 6 months. 
Adverse events included percutaneous lead (12%) and pump pocket (2%) infections, 
device thrombosis (2%), perioperative (3%) and post-operative (6%) stroke, and the 
need for right ventricular mechanical support (5%). Of the 42 pts supported > 1 year, 9 
have undergone transplantation, 2 recovered and had the LVAD removed, 5 died, and 26 
remain ongoing with a median support duration of 513 days.
Conclusions: These results support the use of the HM2 continuous ﬂow LVAD for long 
term support in pts being bridged to cardiac transplant.
1036-305 Rosuvastatin Improves Diastolic Stiffness in 
Heart Failure With Preserved Ejection Fraction 
in Hypertensive Rat Even After Development of 
Ventricular Hypertrophy
Sung-A Chang, Hye-Won Lee, Song-Yi Kim, Dong-A Kwon, Hyuk-Jae Chang, Yong-Jin 
Kim, Dae-Won Sohn, Byung-Hee Oh, Young-Bae Park, Yun-Shik Choi, Department of 
Internal Medicine, Seoul National University Hospital, Seoul, South Korea
Background: Heart failure with preserved ejection fraction (HFPEF) is common and 
signiﬁcant cardiovascular cause of morbidity and mortality. Recently favorable effect of 
statins on heart failure patients was reported. We evaluated the effect of rosuvastatin on 
the cardiac remodeling and function in model of HFPEF with left ventricular hypertrophy 
(LVH) in hypertensive rats.
Methods: Dahl salt-sensitive rats were fed with high salt diet until 13 weeks of age. After 
LVH and diastolic dysfunction was conﬁrmed by echocardiography, rats were randomly 
assigned to control and statin groups (n=10 in each group). Statin group were treated 
with rosuvastatin until 20 weeks of ages via gastric gavage. Serial echocardiography and 
hemodynamic monitoring by miniaturized conductance catheter were performed.
Results : Echocardiographic parameters did not show signiﬁcant difference between 
groups. In hemodynamic monitoring, systolic functional parameters were similar between 
groups, whereas end diastolic pressure-volume relationships were lower in statin group, 
suggesting improvement of myocardial stiffness in this group (p<0.05). Pathological 
analysis showed attenuation of interstitial and peri-vascular ﬁbrosis in statin group.
Conclusion: Statin therapy on HFPEF which started after LVH development and diastolic 
dysfunction did not alleviate LVH, but attenuated the myocardial ﬁbrosis and the 
progression of myocardial stiffness. 
1036-306 ß1-Adrenergic Receptor Polymorphism Predicts Mental 
Stress-Induced Myocardial Ischemia in Patients With 
Coronary Artery Disease
Mustafa Hassan, Kaki M. York, Haihong Li, Qin Li, Yan Gong, Taimour Y. Langaee, Roger 
B. Fillingim, Julie A. Johnson, David S. Sheps, University of Florida, Gainesville, FL
Background: Acute Mental stress is associated with sympathetic adrenergic stimulation 
and concomitant increases in blood pressure and heart rate. Heritable individual 
differences in cardiovascular functional response to mental stress may conceivably 
arise from genetic variations in adrenergic receptors, which might produce excessive 
hemodynamic response to mental stress or create other conditions favoring the 
development of myocardial ischemia. In this study, we sought to examine the relationship 
between hemodynamic responses to mental stress and Mental Stress-induced Myocardial 
Ischemia (MSIMI) and ﬁve common functional polymorphisms of ß1 (ADRB1) and ß2 
adrenergic receptors (ADRB2).
Methods: Participants were 148 patients [45 (30%) females] with documented history of 
CAD and a mean age of 64±9 years. Mental stress was induced via a public speaking task. 
Blood samples were collected and genotyped for ﬁve common functional polymorphisms 
of ADRB1 (codon 49 and 389) and ADRB2 (codon 16 and 27 and nucleotide 523). 
Rest and stress myocardial perfusion imaging was performed. MSIMI was deﬁned as 
new or worsening perfusion defects during mental stress with a summed (stress to rest) 
difference score of q3.
Results: There was a signiﬁcant difference in the prevalence of MSIMI between genotype 
groups for codon 49 ADRB1. MSIMI occurred three times more frequently in patients 
homozygous for the Ser49 allele [31 patients (30%)] compared to 4 patients (10%) in the 
Gly49 allele carriers (p=0.015). The adjusted odds ratio for the effect of genotype (Ser/Ser 
versus Gly carriers) on MSIMI was 3.9 (95% CI=1.2-12.5, p=0.020).
Conclusions: Our ﬁndings indicate an association between a common genetic variation 
in ADRB1 and myocardial ischemic response to mental stress in patients with CAD. This 
polymorphic genetic marker may help identify patients at increased risk for mental stress-
induced adverse outcomes.
1036-307 Mechanical Asynchrony Is an Independent Predictor of 
Death or Development of Heart Failure After Myocardial 
Infarction in Patients With Left Ventricular Dysfunction, 
Heart Failure, or Both: The VALIANT Echo Study
Sung Hee Shin, Chung-Lieh Hung, Amira Hassanein, Anil Verma, Mikhail Bourgoun, 
Lars Kober, Jalal K. Ghali, Eric J. Velazquez, Scott D. Solomon, Brigham and Women’s 
Hospital, Boston, MA
Background: Mechanical asynchrony is considered an independent risk factor for adverse 
cardiovascular outcomes in patients with heart failure (HF). However, its importance as a 
risk factor after myocardial infarction (MI) is not well deﬁned.
Methods: The VALsartan In Acute myocardial iNfarcTion (VALIANT) echo study 
prospectively enrolled 603 patients with left ventricular (LV) dysfunction, HF, or both 
following MI (mean 5 days). B-mode speckle tracking utilizing Vector Velocity Imaging 
(Siemens, Inc.) was used to assess ventricular synchrony in 377 patients who had image 
quality sufﬁcient for analysis. Time to regional peak velocity (Ts) and strain rate (Tsr) 
were measured among 12 LV segments from the apical 4- and 2-chamber views and the 
relationship between the standard deviation (SD) of Ts and Tsr and clinical outcome of 
death or HF was assessed.
Results: In a multivariate Cox model, adjusting for age, eGFR, prior MI, prior HF, 
hypertension, diabetes, Killip class, atrial ﬁbrillation, LV ejection fraction, and primary 
percutaneous transluminal coronary angioplasty for index MI, SD_Ts (HR/ms 1.008; 95% 
CI, 1.001-1.02, P=0.022) and SD_Tsr (HR/ms 1.008, 95% CI 1.0001-1.02, P=0.046) (Fig) 
were independent predictors of death/HF (n= 105 [28.6%])
Conclusion: LV asynchrony is independently associated with increased risk
of death or HF after MI, suggesting that contractile pattern may play a role in post-MI 
prognosis.
1036-308 Diagnostic Accuracy of Noninvasive Coronary 
Angiography With 64-Row Multidetector Computed 
Tomography: A Prospective Multicenter Trial
James K. Min, James G. Jollis, David Dowe, Matthew J. Budoff, The VCT Study Group, 
Cornell University Medical Center, New York, NY, Harbor UCLA Medical Center, Los 
Angeles, CA
Background: Although single-center studies have shown promise for non-invasive 
angiography by 64-row computed tomographic coronary angiography (CCTA), no 
prospective multicenter trial has yet been performed. This study evaluated the diagnostic 
accuracy of 64-row CCTA to detect obstructive coronary stenosis compared to quantitative 
coronary angiography (QCA).
Methods: 16 sites prospectively enrolled 232 patients (pts) [59.5% male, 57 yrs] with chest 
pain referred for invasive coronary angiography (ICA). Pts underwent CCTA (Lightspeed 
VCT/Visipaque 320, GE Healthcare, London, UK) prior to ICA. CCTAs were graded on a 
15-segment AHA model by 3 blinded readers for presence of obstructive stenosis (>50% 
or >70%) by consensus (>or=2 of 3); ICAs were independently graded for % stenosis by 
QCA, considered the reference standard. Efﬁcacy of CCTA was assessed including all 
vessel segments for per-patient and per-vessel analyses.
Results: A total of 82 >50% stenoses in 49 (21.3%) pts, and 31 >70% stenoses in 
28 (12.1%) pts, were identiﬁed by QCA. Per-patient and per-vessel efﬁcacy of CCTA 
compared to QCA are reported in Table 1.
Conclusions: This study represents the ﬁrst prospective multicenter data comparing 64-
row CCTA to QCA, demonstrating high accuracy of CCTA to reliably detect >50% and 
>70% stenosis in chest pain pts being referred for ICA. The high negative predictive value 
observed (98-99%) indicate that CCTA is also an effective non-invasive alternative to 
exclude obstructive coronary stenosis.
Efﬁcacy of CCTA vs QCA
Sensitivity(%) 
(95% CI)
Speciﬁcity(%) 
(95% CI)
Positive Predictive 
Value(%) 
(95% CI)
Negative Predictive 
Value(%) 
(95% CI)
Per Patient
>50% 92% (80-98%)
79% 
(73-85%)
56% 
(45-67%)
98% 
(94-100%)
>70% 93% (93-76%)
81% 
(75-86%)
43% 
(30-56%)
99% 
(96-100%)
Per Vessel
>50% 83% (72-90%)
89% 
(87-91%)
44% 
(36-53%)
99% 
(97-99%)
>70% 85% (68-95%)
92% 
(90-94%)
33% 
(23-44%)
99% 
(99-100%)
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1036-309 The Prevalence and Prognostic Value of Cardiac 
Troponin T Elevation in Ambulatory Patients With 
Stable Coronary Artery Disease
Bill Pei-Chin Hsieh, Mary A. whooley, Nelson B. Schiller, San Francisco Veterans 
Affairs Medical Center, San Francisco, CA, University of California, San Francisco, San 
Francisco, CA
Background: In patients with stable coronary artery disease (CAD), silent myocardial 
ischemia and augmented risk for congestive heart failure and cardiovascular death may 
exist despite apparent clinical stability. We sought to investigate whether cardiac Troponin 
T (cTnT) serves as an independent marker for CAD severity and future events.
Methods: We studied 988 patients with stable CAD enrolled in the Heart & Soul study 
who had plasma cTnT measurements before performing exercise treadmill testing with 
stress echocardiography.
Results: Of the studied population, 58 patients or 5.9% had detectable cTnT levels, 
q0.01 µg/ml (0.01-0.72 µg/ml). The group with cTnT elevation, when compared with 
the remainder was signiﬁcantly associated with the presence of one of the following; 
diabetes, left ventricular ejection fraction < 50%, moderate to severe diastolic dysfunction, 
left ventricular end-diastolic volume q 75 ml/m2 or baseline wall motion abnormalities (OR 
5.6, 95% CI 2.5-12.5, p<0.001). In both univariate and multivariate analyses adjusted for 
clinical predictors of severe CAD, deﬁned as weekly angina plus one of the following; 
hypertension, hyperlipidemia, age >55, diabetes, smoking or previous myocardial infarction 
(MI), cTnT elevation was independently associated with the presence of exercise induced 
ischemia by echocardiography (OR 2.0, 95% CI 1.1-3.6, p = 0.03). During a mean follow 
up period of 4.3 (0.1-6.5) years, patients with detectable cTnT had signiﬁcantly more 
cardiovascular events (non-fatal MI, heart failure, severe arrhythmia, revascularization, 
death from coronary heart disease), compared with those without detectable cTNT in 
unadjusted analysis (HR 3.6, 95% CI 2.6-5.0, p<0.001), and in multivariate analyses 
adjusted for creatinine clearance (HR 2.8, 95% CI 2.0-4.1, p<0.001); exercise inducible 
ischemia (HR 2.0, 95% CI 1.6-2.5, p<0.001); or baseline characteristics (HR 1.8, 95% CI 
1.0-3.1, p=0.04).
Conclusions: In ambulatory patients with stable CAD, the prevalence of cTnT elevation 
was 5.9%. Detection of cTnT was independently associated with the presence of inducible 
ischemia and predicted adverse cardiovascular outcomes.
1036-310 Sex, Age and Outcome of Non-ST Elevation Acute 
Coronary Syndrome: An Analysis of the CRUSADE 
Initiative
Jacqueline E. Tamis-Holland, Anita Y. Chen, Matthew T. Roe, Angela M. Palazzo, Amy 
Chorzempa, Eric D. Peterson, W. Brian Gibler, E. Magnus Ohman, Judith S. Hochman, 
St. Luke’s-Roosevelt Hospital Center, New York, NY, Duke University, Durham, NC
Background: Prior studies have demonstrated that women with coronary artery disease 
have a worse prognosis than men. Among patients with MI, or those undergoing PCI/
CABG, this difference was particularly pronounced in younger women and men.
Methods: We analyzed data on 151,783 patients (40% women) at 565 hospitals between 
1/1/2001 and 9/30/2006 who were enrolled in The CRUSADE Quality Improvement 
Initiative. Baseline characteristics and in-hospital mortality were compared by sex across 
age quintiles among patients presenting with non-ST-segment elevation myocardial 
infarction (NSTEMI). Logistic generalized estimating equations method was used to 
assess the effect of sex and age on mortality.
Results: Women had worse risk proﬁles than men across all age groups. In particular, 
younger women tended to have more high risk features than younger men, including 
more DM, CHF on presentation and ST-segment depression. Figure 1 depicts the 
unadjusted in-hospital mortality for women and men by age groups. Younger women 
had higher mortality than younger men; mortality was similar among older women and 
men. Even after adjustment for differences in baseline characteristics and use of initial 
therapies, younger women still had a 57% higher mortality than younger men (Adjusted 
OR: women vs. men with age <45 years: 1.57 (95% CI: 1.04 to 2.37) (P < 0.0001 for age 
and sex interaction).
Conclusions: Compared with similarly aged men, younger women but not older women 
with non-ST-segment elevation ACS have higher mortality.
1036-311 A Degradation Product of GLP-1 Confers Protection 
Against Acute Myocardial Ischemia Reperfusion Injury 
in Diabetes Mellitus
Susheel Gundewar, John W. Elrod, Sang Yong Ji, Saurabh Jha, Iris Toedt-Pingel, 
Xuelaing Due, Diane Edelstein, David J. Lefer, Michael Brownlee, Albert Einstein 
College of Medicine, Bronx, NY
Background: Cardiovascular disease is the leading cause of diabetes related death. 
GLP1do peptide is a degradation product of GLP-1 that inhibits hyperglycemia-induced 
production of oxidant species and prevents the inactivation of both eNOS and prostacyclin 
synthase in both cells and diabetic animals. We investigated the potential cardioprotective 
effects of GLP1do peptide in two in vivo diabetic murine models of myocardial ischemia-
reperfusion (MI-R) injury. Methods: Diabetic (db/db and STZ-diabetic) mice were treated 
with 2.4 µg/day of GLP1do via Alzet pump for 7 days and subjected to 45 min of left 
coronary artery occlusion and 2 hr of R. At 2 hr of R, hearts were excised and evaluated 
for infarct (INF) size using 2,3,5-triphenyltetrazolium chloride (TTC) staining. Results: 
Both models of diabetic mice exhibited elevated basline blood glucose (BG) values of 
386 ± 25 and 476 ± 35 mg/dl respectively. After 7 days of GLP1do therapy, db/db mice 
exhibited a 48% reduction in BG values. In contrast, no signiﬁcant reduction in BG was 
observed in the STZ-diabetic mice. Importantly, Diabetic (db/db) and STZ-diabetic mice 
treated with GLP1do exhibited a 37% and 45% reduction in INF per area-at-risk (AAR) 
respectively. Conclusion: These results indicate that administration of GLP1do peptide 
confers cardioprotection in diabetic mice by attenuating the extent of myocardial injury 
following I-R. Furthermore, GLP1do peptide mediated cardioprotection appears to be 
independent of its anti-hyperglycemic effects. 
1036-312 Clinical Features and Long-Term Outcomes for Children 
With Left Ventricular Noncompaction: Results From a 
Population-Based Study of Childhood Cardiomyopathy
Piers E.F. Daubeney, Alan Nugent, Patty Chondros, Michael M. Cheung, C. W. Chow, 
Gunnar Sjoberg, Andrew Davis, Ingrid King, Robert G. Weintraub, Royal Children’s 
Hospital, Melbourne, Australia
Background: The long-term outcomes and prognostic variables for childhood left-
ventricular non-compaction (LVNC) have not been well deﬁned.
Methods: This review examines the clinical features and outcomes for children with 
LVNC enrolled in the National Australian Childhood Cardiomyopathy Study. This ongoing, 
population-based study comprises all children with primary cardiomyopathy who 
presented at age 0-10 years, between 1987 and 1996.
Results: 29 patients were identiﬁed, representing 9.2% of the NACCS study population. 
The diagnosis was apparent from echocardiography (n=28), angiography (n=12), direct 
examination (transplant or autopsy) (n=11) and MRI (n=1). The median age (interquartile 
range) at diagnosis was 4.1 (1.2, 15.9) months. Congestive heart failure was the 
presenting symptom in 24/29 (83%). Barth syndrome was present in 7/29 (24%). The initial 
pathophysiology was dilated CM in 26 (90%) and restrictive CM in 2 (7%). The median 
non-compacted:compacted myocardial thickness on echo was 2.55 (IQR 2.1, 3.2). Survival 
free from cardiac transplantation was 69% 1 year after presentation and 44% after 15 
years. Risk factors for death or transplant were an increase in fractional shortening Z 
score over baseline during follow-up (p=0.01), female gender (p=0.02) and sporadic 
LVNC (p=0.03). Four (13.8%) patients had an undulating cardiomyopathy with variable LV 
systolic dysfunction and/or progression to severe LV hypertrophy. The causes of death were 
progressive heart failure in 6 (20.7%) cases and sudden death in 5 (17.2%).
Conclusions: This study deﬁnes the spectrum of childhood LVNC. Long-term survival is 
poor and sudden death is common. Outcomes are related to hereditary characteristics 
and LV systolic function.
1036-313 Prematurity Is a Strong Risk Factor for Developing 
Pulmonary Vein Stenosis
David M. Drossner, Dennis Kim, Kevin O. Maher, William T. Mahle, Emory University 
School of Medicine, Atlanta, GA, Sibley Heart Center, Atlanta, GA
Background: Pulmonary vein stenosis (PVS) is a rare, often lethal anomaly. Risk factors 
for the development of PVS are poorly characterized. In the present study we sought 
to identify risk factors for the development of PVS, paying particular attention to the 
inﬂuence of preterm birth.
Methods: By review of the cardiac database we identiﬁed all subjects with PVS over a 10 
year period at our institution. Those children with Scimitar syndrome and total anomalous 
pulmonary venous connection were not included. Patient related variables were analyzed 
for their association with the development of PVS. PVS was diagnosed by spectral 
Doppler interrogation of the pulmonary veins (continuous, turbulent ﬂow with calculated 
mean gradient > 5 mm Hg).
Results:We identiﬁed 22 patients with PVS who were diagnosed at a median age of 
7 months, range 2 weeks to 35 months. Cardiac catheterization was performed in 20 
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subjects (91%). Stenosis of 2 or more pulmonary veins was present in 14 subjects 
(64%). Associated cardiac defects were common including: atrial septal defect in 10 
(45%), patent ductus arteriosus in 9 (41%), ventricular septal defect in 8 (38%) and 
atrioventricular canal in 3 (14%). Genetic syndromes were present in 5 (23%). The 2 year 
freedom from death or lung transplantation was 45%. The majority of subjects with PVS 
16 (73%) were preterm. Gestational age ranged from 25.5 to 40 weeks. Using National 
Center for Health Statistics estimate of prematurity in our state as a referent, preterm birth 
was strongly associated with the development of PVS, odds ratio 9.3 (95% CI 4.3 -20.6), 
p <.001. Six of the 16 (38%) preterm infants were treated for bronchopulmonary dysplasia 
before being diagnosed with PVS.
Conclusions: Prematurity is a strong risk factor for the development of PVS. Interestingly 
many of these patients also have intracardiac shunt lesions which may act in concert 
with preterm endothelium to produce PVS. Given that PVS is typically not identiﬁed until 
several months of age it is possible that earlier interventions to eliminate shunt lesions 
may impact the development of PVS.
1036-314 Incidence of Aneurysm Formation After Dacron Patch 
Aortoplasty Repair for Coarctation of the Aorta: Long-
Term Results in a Single Center
Michael G. Earing, David Koppein, Peter Bartz, Jane Sowinski, Andrew Pelech, Bert 
Litwin, James Tweddell, Children’s Hospital of Wisconsin, Milwaukee, WI, Medical 
College of Wisconsin, Milwaukee, WI
Background: Following coarctation of aorta (CoA) repair, aneurysms in region of previous 
repair are one of most dangerous late complications. Reported incidence of aneurysms 
range from 5-33%, with particular high incidence in pts repaired with Dacron patch 
aortoplasty (DAP). We sought to determine incidence of aneurysmal formation in pts 
following CoA repair using DAP.
Methods: From 1977-1986 at Children’s Hospital of Wisconsin, 70 pts (45 males) had 
CoA repair using DAP (mean age 4.7 yr, range 0.1- 19). Coexisting conditions included: 
bicuspid aortic valve (50), PDA (12), and VSD (12). The status of each pt was determined 
by chart review.
Results: There were 4 early deaths. Of 66 early survivors, we have long-term follow-up 
on 77% (51/66) of the cohort, mean duration 21.6 yrs (range 12-30yrs). Of early survivors 
53% (27/51) have required a second intervention. Most frequent interventions included: 
aneurysm repair (15), VSD closure (6), arch revision for residual arch obstruction (3), 
aortic valve repair/replacement (3), and mitral valve replacement (1). Overall, 41% (21/51) 
have developed an aneurysm at site of previous repair: 6 of these pts died from aneurysm 
rupture/dissection, 3 required emergent surgery after dissection and survived, another 
12 underwent elective repair. Overall, late survival was 80% (41/51). Causes of late 
mortality were: aneurysm rupture/dissection (6), myocardial failure (2), and accidental 
(2). Of late survivors, 49% (20/41) have systemic hypertension. No pt has developed 
a cerebrovascular accident, CAD, or endocarditis. By echo, 4 pts have residual arch 
obstruction, mean gradient 24 mm Hg (range 20-30). No pt had signiﬁcant aortic valve 
stenosis but 4 pts had moderate regurgitation. All pts were in NYHA functional class I-II.
Conclusions: Following coarctation of aorta repair using Dacron patch aortoplasty, late 
complications are common and include systemic hypertension and aneurysm formation 
with risk for rupture/dissection, emphasizing the need for life-long follow-up.
1036-315 Nine Independent Regional ST-Elevation Myocardial 
Infarction Networks Exceed D2B Alliance Benchmark
Ivan C. Rokos, Regional STEMI Networks Collaborative Group, UCLA - Olive View, Los 
Angeles, CA
Background: In 2006, the ACC launched the Door-to-Balloon (D2B) Alliance, a national 
quality improvement initiative that encouraged hospitals to achieve a q75% rate of D2B 
a90 minutes for primary percutaneous coronary intervention (PPCI) in acute ST-elevation 
myocardial infarction (STEMI). Concurrently, multiple regional networks organized pre-
hospital cardiac triage systems that utilized pre-hospital electrocardiograms (PH-ECG) 
to diagnose STEMI followed by direct transport to PPCI-capable hospitals that are 
designated as STEMI Receiving Centers (SRC).
Methods: As part of each region’s quality assurance program, multiple independent 
databases were created of all consecutive patients with a PH-ECG+ for STEMI. The 
primary endpoint of this pooled analysis was the overall rate of D2B a90 minutes, starting 
with the date of each region’s SRC network launch through August 31, 2007. Self-
transport and inter-hospital transfer patients were not included.
Results: Data from all nine regions demonstrated that 2613 patients had a PH-ECG+ for 
STEMI. Of these, 1981 patients (Table) underwent PPCI and 1680 (85%, 95% CI = 83%, 
86%) had a D2B a90 minutes.
Conclusion: Nine regional STEMI Receiving Center networks demonstrated a combined 
85% rate of D2B a90 minutes, and each region surpassed the current D2B Alliance 
benchmark. These SRC networks integrated pre-hospital ECG identiﬁcation of STEMI 
patients with immediate transport and early activation of the receiving PPCI-capable 
hospital. 
Start 
Date Region
Population 
(millions)
# 
SRCs
PH-ECG+ 
and PPCI+
% Rate of 
D2Ba90 min.
Jun-03 Marin County, CA 0.3 1 231 78%
Apr-05 Orange County, CA 3.0 12 563 85%
Jan-06 Jackson-Josephine Co, OR (Medford) 0.3 1 85 78%
Apr-06 Oakland County, MI (Beaumont) 1.2 1 112 80%
May-06 Minneapolis/St Paul, MN 1.6 3 184 87%
Dec-06 Los Angeles County, CA 10.0 31 469 90%
Jan-07 Ventura County, CA 0.8 3 67 85%
Jan-07 San Diego County, CA 3.0 13 210 86%
Mar-07 Fulton County, GA (Atlanta) 0.8 5 60 80%
COMBINED= 21 70 1981 85%
1036-316 Frequency and Predictors of Stress Testing Prior to 
Elective Percutaneous Coronary Interventions in a 
Medicare Population 
Grace A. Lin, R. Adams Dudley, F. L. Lucas, David J. Malenka, Rita F. Redberg, 
University of California San Francisco, San Francisco, CA
Background: Current guidelines for elective percutaneous coronary intervention (PCI) 
suggest that documenting ischemia should be done to determine the need for PCI in 
patients with stable coronary artery disease. Our objective was to determine the frequency 
and predictors of stress testing prior to elective PCI in a Medicare population.
Methods: We examined the Medicare Provider Analysis, Physician/Supplier and 
Denominator Files for a random 20% sample of Medicare beneﬁciaries for all fee-for-
service patients 65 years or older who had elective PCI in 2004. We calculated the 
proportion of patients who underwent stress testing in the 90 days prior to PCI and 
examined predictors of stress testing using a hierarchical logistic regression model.
Results: We identiﬁed 22,750 patients who had elective PCI in 2004. Nationally, only 
44.8% of patients underwent stress testing in the 90 days prior to PCI. Proportions varied 
widely among hospital referral regions from 19% to 70.6% (interquartile range 39.3%, 
50.9%). In the multivariate model, signiﬁcant predictors of not receiving a stress test prior 
to PCI included female sex (odds ratio 0.92, 95% conﬁdence interval 0.86-0.97), age > 75 
(OR 0.84, 0.72-0.96), prior catheterization (OR 0.45, 0.38-0.55), chronic lung disease (OR 
0.84, 0.78-0.89), congestive heart failure (OR 0.85, 0.79-0.92), and having a physician 
who did a high volume of PCI (OR 0.86, 0.77-0.96). Patients of African-American race 
(OR 1.20, 1.04-1.38) or having a diagnosis of chest pain (OR 1.26, 1.05-1.52) were more 
likely to undergo stress testing prior to PCI in our cohort.
Conclusions: In the majority of Medicare patients with stable coronary artery disease, 
stress testing to document ischemia is not being done prior to elective PCI. A variety of 
patient, physician, and geographic factors predicted receipt of stress testing. As current 
guidelines generally require documentation of ischemia prior to elective PCI, this ﬁnding 
suggests a lack of application of guidelines, meaning that interventions which are not 
useful or effective may be common in the Medicare population. Future research should 
focus on promoting adherence to guidelines and decreasing variation in care.
1036-317 Continuous Curvatures in a Model of the Human 
Cardiac Geometry
Han Li, Salvatore A. Chiaramida, Frederick J. Vetter, University of Rhode Island, 
Kingston, RI, Medical University of South Carolina, Charleston, SC
Background: Curvature of the cardiac geometry has a major impact on action potential 
propagation velocity and regional wall stress, but most cardiac geometry models lack 
detailed curvature representations. A surface with continuous second-order derivatives 
is required to model continuous curvatures. The goal of this research was to develop a 
human cardiac geometry model with quantitative surface curvatures.
Methods: Surface coordinates of a human cardiac geometry were measured from CT 
images. We used the ﬁnite element method to ﬁt continuous surfaces to the measured 
coordinates of the epicardium, left ventricle (LV), and right ventricle. Surfaces were 
interpolated using biquintic Hermite basis functions, which provide continuous second 
derivatives at the ﬁnite element boundaries. Regional curvatures were computed from 
the reconstructed surfaces.
Results: Four surfaces were ﬁt to 87,237 points of the human cardiac geometry with a 
root-mean-squared error of ±0.0099 mm. The direction and magnitude of the principal 
curvatures were rendered as vectors on the LV geometry, and as a color map on a 
Hammer projection of the LV (see Figure). The maximum and minimum curvatures on the 
LV endocardium were 3.75/mm and -3.62/mm, respectively.
Conclusions: Second-order continuity of the cardiac surfaces can be accurately 
represented with biquintic Hermite ﬁnite element surfaces. This approach will be valuable 
for analyses of wall cardiac wall mechanics and electrical propagation.
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1036-318 Sodium Bicarbonate to Prevent Acute Kidney Injury 
After Cardiopulmonary Bypass: A Multiple-Blind, 
Randomized Controlled Trial
Michael Haase, Anja Haase-Fielitz, Rinaldo Bellomo, Prasad Devarajan, Duska Dragun, 
Austin Health, Melbourne, Australia
Background: Acute kidney injury after cardiac surgery is common and associated with 
increased morbidity and mortality. Urinary alkalinization may be protective in this setting 
by reducing cardiopulmonary bypass-associated generation and toxicity of reactive 
oxygen species. We tested whether peri-operative sodium bicarbonate infusion would 
attenuate acute kidney injury in cardiac surgical patients.
Methods: We enrolled 100 cardiac surgical patients at high risk of post-operative acute 
kidney injury in a multiple-blind, randomized controlled trial. Patients were randomized to 
either twenty-four hours of intravenous sodium bicarbonate (4mEq/kg) or sodium chloride 
(4mEq/kg). The primary outcome measure was the proportion of patients developing post-
operative acute kidney injury deﬁned as an increase in plasma creatinine concentration 
>0.5mg/dL (44µmol/L) or >25% of baseline within the ﬁrst ﬁve post-operative days. 
Renal secondary outcomes included changes in plasma creatinine, plasma urea, urinary 
neutrophil gelatinase-associated lipocalin and urinary neutrophil gelatinase-associated 
lipocalin/urinary creatinine ratio.
Results: Patients were well balanced for baseline characteristics. Sodium bicarbonate 
infusion increased plasma bicarbonate concentration (P<0.001), base excess (P<0.001), 
plasma pH (P<0.001) and urine pH (P<0.001). Fewer patients in the sodium bicarbonate 
group (16/50) developed post-operative acute kidney injury compared to the control 
group (26/50) (OR 0.43 [95% CI 0.19-0.98]), (P=0.04). The increase in plasma creatinine, 
plasma urea, urinary neutrophil gelatinase-associated lipocalin and urinary neutrophil 
gelatinase-associated lipocalin/urinary creatinine ratio was less in sodium bicarbonate 
patients, (P=0.01; P=0.04; P=0.009; P=0.004). There were no signiﬁcant side effects of 
sodium bicarbonate therapy.
Conclusion: Sodium bicarbonate loading and continuous infusion is associated with a 
lower incidence of acute kidney injury in high-risk cardiac surgical patients undergoing 
cardiopulmonary bypass. A multi-center phase III trial of this intervention seems justiﬁed. 
ClinicalTrials.gov, NCT00334191.
1036-319 Survival Beneﬁt With Beta-Blocker Therapy in a Cohort 
of 623 Patients With Severe Aortic Regurgitation
Unnati Sampat, Padmini Varadarajan, Rami Turk, Reena Patel, Ashvin Kamath, Sumit 
Kandhar, Ramdas G. Pai, Loma Linda University school of Medicine, Loma Linda, CA
Background: Beta blockers are thought to be contraindicated in patients with severe 
aortic regurgitation (AR), due to its effect on the heart rate, which increases the duration 
of diastole during which AR occurs. As AR causes neuroendocrine activation as well 
similar heart failure states, we investigated the effect of beta-blocker therapy on survival 
in severe AR patients.
Methods: Our echocardiographic database was screened for patients with severe AR 
from 1993 to 2007, yielding a total of 623 patients. Detailed chart reviews were performed 
for clinical, demographic and therapeutic data. Survival data was obtained from social 
security death index and was analyzed as a function of beta-blocker therapy.
Results: Of the 623 patients with severe AR, 39 % were women, age 61+18 years, LV 
ejection fraction 54+19%, and diabetes mellitus 13 %, CAD 32%. Mean duration of follow 
up was 4.8 years. Out of the 623 patients 318 patients (52 %) were on a beta-blocker. Beta-
blocker therapy was associated with a higher survival rate compared to those without (1 and 
5 year survival rates 90 and 70% compared to 78 and 60% respectively, p=0.03). Using the 
Cox proportional hazards model, beta-blocker therapy remained an independent predictor 
of better survival after adjusting for age, gender, ejection fraction, diabetes, CAD, CHF and 
aortic valve replacement (HR 0.762, 95% CI 0.582-0.999, p=0.04).
Conclusions: Beta-blockers therapy is associated with independent survival beneﬁt in 
patients with severe AR. 
1036-320 Impact of Global Afterload on Left Ventricular 
Myocardial Contractility in Asymptomatic Aortic 
Stenosis: A SEAS Substudy
Dana Cramariuc, Giovanni Ciofﬁ, Åshild E. Rieck, Richard Devereux, Eva M. Staal, 
Simon Ray, Kristian Wachtell, Eva Gerdts, Institute of Medicine, University of Bergen, 
Bergen, Norway
Background: In aortic stenosis (AS), global afterload reﬂects combined valvular and 
arterial resistance to left ventricular (LV) ejection. The impact of LV global afterload on 
ejection fraction (EF) has been evaluated only in symptomatic AS, and the impact on LV 
myocardial systolic function has not been adressed.
Methods: Baseline echocardiograms in 1591 patients with asymptomatic mild-moderate 
AS (67±10 years, 51% hypertensive), recruited in the Simvastatin Ezetimibe in AS (SEAS) 
study evaluating placebo-controlled combined simvastatin and ezetimibe treatment in 
AS, were used to assess global afterload as valvulo-arterial impedance (Zva) and LV 
myocardial function as stress-corrected midwall circumferential shortening (scMWS). The 
study population was divided into tertiles of Zva. ScMWS was considered low if < 89.2% 
and EF if < 50%.
Results: Prevalence of low scMWS increased and aortic valve area index decreased 
(tertile 1: 11%-0.72 cm²/m², tertile 2: 28%-0.67, tertile 3: 63%-0.63, respectively) with 
increasing Zva (both p<0.001). Low EF was present in 2% of patients irrespective of Zva. 
In logistic regression analysis, Zva was a main predictor of low scMWS independent 
of male gender, concentric LV geometry, LV hypertrophy (all p < 0.001), concomitant 
hypertension or aortic regurgitation (Table).
Conclusions: Global afterload has an important independent impact on LV myocardial 
contractility in asymptomatic mild-moderate AS. 
Table
Independent Correlates of Low scMWS OR [95% CI] p
Zva 2.49 [2.21-2.80] <0.001
Male gender 2.55 [1.83-3.55] <0.001
Concentric LV geometry 8.78 [5.60-13.77] <0.001
LV hypertrophy 11.38 [7.77-16.66] <0.001
Aortic regurgitation 0.98 [0.71-1.33] 0.878
Concomitant hypertension 0.76 [0.56-1.04] 0.085
1036-321 Differential Effect of Baseline Antihypertensive 
Medications on Blood Pressure Changes in Patients 
With Osteoarthritis in the Multinational Etoricoxib and 
Diclofenac Arthritis Long-Term (MEDAL) Study:  
A Multivariate Analysis
Henry Krum, Sean P. Curtis, D. Craig Brater, Loren Laine, Matthew R. Weir, A. Kaur, 
Hongwei Wang, Steven S. Smugar, Gary Swergold, Christopher P. Cannon, Merck 
Research Laboratories, Rahway, NJ
Introduction: NSAIDs can attenuate the antihypertensive (antiHTN) effects of beta-
blockers (BBs), diuretics, and ACE inhibitors, but have little effect on calcium channel 
blockers (CCBs). This difference may be due to the intrinsic natriuretic and vasodilatory 
properties of CCBs, which are likely independent of prostaglandins (PG), and thus less 
susceptible to NSAID-related PG imbalances.
Methods: Post-hoc multivariate analysis of patients with osteoarthritis receiving etoricoxib 
60 mg (N=6769) or diclofenac 150 mg (N=6700) daily (mean duration, 20 months) 
evaluated the differential effect of baseline antiHTN therapy vs no antiHTN therapy on the 
change from baseline in systolic blood pressure (SBP) at 4 months*, and the proportion 
of patients exceeding the predeﬁned limits of change (PLoC) in SBP†. Statistical analysis 
details are described in the Table.
Results: Patients on CCBs had a numerically lower change in SBP at month 4, and a 
similar incidence of exceeding SBP PLoC as patients with no antiHTN use (Table). All 
other medications were associated with SBP increase, which was statistically signiﬁcant 
for multi-drug therapy and mono-renin-angiotensin therapy. Excluding CCBs, all antiHTN 
therapies were associated with increased incidences of SBP exceeding PLoC, with 
signiﬁcant ORs for multi-drug therapy, diuretics, and BBs.
Conclusions: CCBs appear to maintain antihypertensive effects with concurrent NSAID 
therapy better than other antihypertensive drug classes.
JACC March 11, 2008  ABSTRACTS - Best Poster Award Competition A381 
B
est P
oster A
w
ard C
om
petition
Table. 
Multivariate analysis for SBP change at Month 4 and SBP PLoC by baseline antiHTN 
use (ranked by signiﬁcance of risk markers)
Antihypertensive Medications vs. No 
Medications
$SBP at Month 4, mm Hg 
(95% CI) p-Value
Multi-drug therapy 1.58 (0.46 , 2.70) 0.0057
Mono-renin-angiotensin‡ 1.22 (0.01 , 2.42) 0.0474
Mono-BB 0.96 (-0.51 , 2.42) 0.1995
Mono-other§ 1.84 (-1.49 , 5.16) 0.2791
Mono-CCB -0.55 (-2.17 , 1.07) 0.5035
Mono-diuretics 0.42 (-1.11 , 1.95) 0.5931
SBP PLoC, 
Odds Ratio (95% CI) p-Value
Multi-drug therapy 1.54 (1.13 , 2.12) 0.0071
Mono-diuretics 1.65 (1.11 , 2.47) 0.0139
Mono-BB 1.53 (1.04 , 2.26) 0.0319
Mono-renin-angiotensin‡ 1.29 (0.92 , 1.82) 0.1393
Mono-other§ 1.59 (0.72 , 3.51) 0.2539
Mono-CCB 1.04 (0.65 , 1.67) 0.8574
Univariate markers were analyzed with the risk marker and control factors (SBP and 
DBP in 10 mm Hg units and treatment group) as covariates. Signiﬁcant single risk 
markers (p<0.05) were passed into the multivariate model. Backward elimination 
approach was applied with A=0.05 for covariates staying in the model. 
*BP change from baseline was analyzed as a continuous variable using an analysis 
of covariance model with covariates baseline SBP, baseline DBP, treatment, age (q65, 
<65), BMI (q30, <30), gender, race (white, non-white), history of hypertension and 
antihypertensive use. 
†SBP PLoC was deﬁned as follows: consecutive measurements >140 mm Hg and 
change from baseline >20 mm Hg. PLoC was analyzed as a binary variable using a 
logistic regression model with covariates baseline SBP, treatment, age (q65, <65), 
gender, history of hypertension, and antihypertensive use. 
‡Includes all drugs that act on the renin-angiotensin system (i.e., ACE inhibitors and 
angiotensin receptor antagonists) 
§Includes A-blockers, other centrally-acting drugs, and peripheral vasodilators.
efﬁcacy of DES may be different when deployed in SVGs compared to native vessels.
1036-322 Use of Drug-Eluting Stents in Saphenous Vein Graft 
Lesions
Tami L. Bair, Joseph B. Muhlestein, Heidi T. May, Benjamin D. Horne, Qunyu Li, Jeffrey 
L. Anderson, Donald L. Lappé, Intermountain Medical Center, Murray, UT
Background: Saphenous vein grafts (SVGs) experience a high rate of restenosis following 
percutaneous coronary intervention (PCI). Stenting SVG lesions has been shown to be 
more effective than balloon angioplasty. For most patient subpopulations undergoing PCI 
of native vessels, drug-eluting stents (DES) have been shown to be superior to bare metal 
stents (BMS) for prevention of major adverse cardiac events (MACE). The objective of 
this study was to assess the potential beneﬁt of DES compared to BMS in the treatment 
of SVG lesions.
Methods: From April 2002 to June 2007, in a single institution, 377 (BMS=176, DES=201) 
consecutive patients underwent PCI with stent implantation for SVG lesions. Baseline 
data were collected and all patients were followed for 1-year to assess the incidence of 
death, myocardial infarction (MI), Death/MI, target lesion revascularization (TLR), and 
MACE (death, MI or TLR).
Results: Age averaged 69±11 years, 87% were male, and 31% diabetic. At 1-year, death 
occurred in 5.5% of DES and 1.1% of BMS (univariable: OR=5.04, p=0.04; multivariable: 
OR=5.86, p=0.03); MI occurred in 9.0% of DES and 11.4% of BMS (univariable: OR=0.77, 
p=0.44; multivariable: OR=0.77, p=0.46); Death/MI occurred in 12.9% of DES and 11.9% 
of BMS (univariable HR=1.10, p=0.80; multivariable HR=1.16, p=0.64); TLR occurred in 
3.5% of DES and 2.3% of BMS (univariable: OR=1.55, p=0.49; multivariable: OR=1.32, 
p=0.67); and MACE occurred in 15.9% of DES and 14.2% of BMS (univariable: OR=1.14, 
p=0.64; multivariable: OR=1.18, p=0.57).
Conclusions: In this study of patient undergoing SVG stent deployment and followed for 
1-year, no signiﬁcant advantage of DES over BMS was found. TLR rates were low in both 
stent groups, indicating a physician tendency towards non-invasive medical management 
of post-stent SVG restenosis. A trend towards a reduction in MI was found with DES, but 
this was offset by an increase in death. These data suggest that the efﬁcacy of DES may 
be different when deployed in SVGs compared to native vessels.
1036-323 Is Preoperative Statin Therapy Associated With a 
Decrease in the Incidence of Postoperative Renal 
Insufﬁciency?
Salim S. Virani, Venkatesh Polsani, Vei-Vei Lee, MacArthur Elayda, James M. Wilson, 
Christie M. Ballantyne, St. Luke’s Episcopal hospital/ Texas Heart Institute, Houston, TX, 
Baylor College of Medicine, Houston, TX
Background: There is limited information on the reno-protective effects of statins. We 
hypothesize that pre-operative statin therapy is associated with improved renal outcomes 
in patients undergoing cardiac surgery.
Methods: Retrospective review of patients undergoing cardiac surgeries at St. Luke’s 
Episcopal Hospital/Texas Heart Institute from Jan 2003 through Dec 2006, who are 
captured in the Texas Heart Institute Research Database was performed. Patients on 
chronic dialysis were excluded. Patients were divided into 2 groups: those who received 
pre-operative statins and those who did not. Primary outcomes of interest included any 
post-operative renal insufﬁciency deﬁned as post-op acute tubular necrosis, post-op 
anuria, and any episode of rising serum creatinine deemed signiﬁcant by the treating 
physician. Post-op renal insufﬁciency was also evaluated as dialysis requiring or not. 
Outcomes were assessed in the entire cohort and in sub-groups of patients undergoing 
isolated coronary artery bypass grafting (CABG), isolated valve surgeries, or combined 
CABG and valve surgeries.
Results: A total of 4,249 patients were included in ﬁnal analysis after excluding 136 
patients (3%) on chronic dialysis. Pre-operative statin therapy was prescribed to 53% of 
patients. Multivariate regression analysis revealed that pre-operative statin therapy was 
associated with decrease incidence of any post-op renal insufﬁciency in the entire cohort 
(OR 0.69, 95%CI 0.52-0.92 p<0.009) as well as renal failure requiring dialysis in patients 
undergoing isolated CABG (n = 2552, OR 0.50, 95%CI 0.30-0.81 p 0.005). In patients 
undergoing either isolated valve surgery (n = 1226) or combined CABG and valve surgery 
(n = 471), pre-operative statin therapy was not associated with a decreased incidence of 
post-op renal insufﬁciency (OR 1.52, 95% CI 0.91-2.54 p 0.11 for isolated valve surgery; 
OR 0.76, 95%CI 0.42-1.37 p 0.36) for combined CABG and valve surgery).
Conclusion: Pre-operative statin therapy is associated with a decreased incidence of 
post-operative renal insufﬁciency in patients undergoing cardiac surgeries. This effect is 
pre-dominantly seen in patients undergoing isolated CABG.
